Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of chagas disease.
Chagas disease remains a serious medical and social problem in Latin America and is an emerging concern in nonendemic countries as a result of population movement, transfusion of infected blood or organs and congenital transmission. The current treatment of infected patients is unsatisfactory due to...
Saved in:
Main Authors: | Renata Sesti-Costa (Author), Zumira A Carneiro (Author), Maria C Silva (Author), Maíta Santos (Author), Grace K Silva (Author), Cristiane Milanezi (Author), Roberto S da Silva (Author), João S Silva (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2014-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Parasiticide Treatment with Benznidazol in the Electrocardiographic, Clinical, and Serological Evolution of Chagas Disease.
by: Abilio Augusto Fragata-Filho, et al.
Published: (2016) -
[Ru(bpy)2(NO)SO3](PF6), a Nitric Oxide Donating Ruthenium Complex, Reduces Gout Arthritis in Mice
by: Ana C. Rossaneis, et al.
Published: (2019) -
Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study.
by: Clareci Silva Cardoso, et al.
Published: (2018) -
Benznidazole-Loaded Polymeric Nanoparticles for Oral Chemotherapeutic Treatment of Chagas Disease
by: Lucas Resende Dutra Sousa, et al.
Published: (2024) -
Access to benznidazole for Chagas disease in the United States-Cautious optimism?
by: Jonathan D Alpern, et al.
Published: (2017)